Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2005
08/23/2005US6933317 PGD2 receptor antagonistic pharmaceutical compositions
08/23/2005US6933294 Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/23/2005CA2119782C Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
08/18/2005WO2005075483A1 Substituted thieno - and thiazolo - [2, 3-d] pyridines as inhibitors of tie2
08/18/2005WO2005075452A1 2-halofuryl/thienyl-3-carboxamides
08/18/2005WO2005074933A1 Small molecule inhibitors of her2 expression
08/18/2005WO2005074922A1 1H-THIENO[2,3-c]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS
08/18/2005US20050182126 2-Thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/18/2005US20050182053 3-amino-6-{4-[2-hydroxy-2-(substituted heteroaryl)ethylamino]-piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxylic acid amides; reductive amination; I kappa B kinase inhibitors; autoimmune diseases; antiinflammatory and anticarcinogenic agents
08/18/2005US20050179013 Hyperpolarizable organic chromophores
08/18/2005DE102004004974A1 Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen Thieno-imino acid derivatives as inhibitors of matrix metalloproteinases
08/18/2005CA2556081A1 2-halofuryl/thienyl-3-carboxamides
08/18/2005CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1562944A1 Pyrazoloquinolines with immunomodulating activity
08/17/2005EP1562917A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
08/17/2005EP1562899A2 N-(indole-2-carbonyl)amides as anti-diabetic agents
08/17/2005EP1562898A1 Indole derivatives as somatostatin agonists or antagonists
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
08/17/2005EP0990650B1 Tricyclic pyrrole or pyrazole derivatives
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215060C Condensed pyrazole compound, composition containing it and its application
08/16/2005US6930184 Functional fluorescent dyes
08/11/2005WO2005073236A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
08/11/2005WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005WO2005046588A3 Compounds, compositions, and methods
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005US20050176960 Diastereomeric crystallization using a single optically active resolving agent, (S)-10-camphorsulfonic acid, and a solvent; optically pure form
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176742 Novel compounds and their use in therapy
08/11/2005US20050176738 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2457459A1 Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
08/10/2005EP1560835A1 Spirocyclic cyclohexane derivatives
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214031C Hydropyridine deriv. acid addition salts
08/09/2005US6927298 Polythiophenes homo- or copolymers is formed by 3,4-ethylenedioxythiophene or 3,4-alkylenedioxythiophenedioxide; light emitting diodes, electroconductive, low molecular weight, printable paste, antistatic layer
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927214 Non-peptide GLP-1 agonists
08/04/2005WO2005070939A1 Synthesis of olanzapine and intermediates thereof
08/04/2005WO2005070938A1 Stable salts of olanzapine
08/04/2005WO2005070937A1 A process for making olanzapine in a polymorph form i
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005032527A3 Benzo (4, 5) thieno (2, 3-d) pyrimidin-4-ones and their use in therapy
08/04/2005WO2005019201A3 Process for the preparation of 4-amino-3-quinolinecarbonitriles
08/04/2005US20050171356 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/04/2005DE10361713A1 Use of oligo-thiophene or oligo-pyrrole compounds or metal-phthalocyanine complexes as electron donors in charge transfer complexes for use in non-volatile memory elements, e.g. multi-bit memory elements
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1558601A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558586A2 Inhibitors of akt activity
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005CN1649877A Process for the preparation of clopidogrel
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649875A 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1648129A Organic non-linear optical chromophore compound containing 1, 3-dithio cyclopentenyl group
08/03/2005CN1648128A Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
08/02/2005US6924283 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
08/02/2005CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
07/2005
07/28/2005WO2005068471A1 New crystalline forms of clopidogrel hydrobromide and methods of their preparation
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
07/28/2005WO2005067644A2 Conjugated small molecules
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
07/28/2005WO2005019224A3 Novel antiinfective compounds
07/28/2005WO2004052891A8 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders
07/28/2005US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide
07/28/2005US20050165037 Process for producing cyclic thioether and synthetic intermediate thereof
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
07/28/2005DE10360793A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
07/28/2005DE10360792A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 214